Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P
Laboratory of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium.
J Exp Med. 1998 May 4;187(9):1477-85. doi: 10.1084/jem.187.9.1477.
Murine L929 fibrosarcoma cells treated with tumor necrosis factor (TNF) rapidly die in a necrotic way, due to excessive formation of reactive oxygen intermediates. We investigated the role of caspases in the necrotic cell death pathway. When the cytokine response modifier A (CrmA), a serpin-like caspase inhibitor of viral origin, was stably overexpressed in L929 cells, the latter became 1,000-fold more sensitive to TNF-mediated cell death. In addition, TNF sensitization was also observed when the cells were pretreated with Ac-YVAD-cmk or zDEVD-fmk, which inhibits caspase-1- and caspase-3-like proteases, respectively. zVAD-fmk and zD-fmk, two broad-spectrum inhibitors of caspases, also rendered the cells more sensitive, since the half-maximal dose for TNF-mediated necrosis decreased by a factor of 1,000. The presence of zVAD-fmk also resulted in a more rapid increase of TNF-mediated production of oxygen radicals. zVAD-fmk-dependent sensitization of TNF cytotoxicity could be completely inhibited by the oxygen radical scavenger butylated hydroxyanisole. These results indicate an involvement of caspases in protection against TNF-induced formation of oxygen radicals and necrosis.
用肿瘤坏死因子(TNF)处理的小鼠L929纤维肉瘤细胞会因活性氧中间体的过度形成而迅速发生坏死性死亡。我们研究了半胱天冬酶在坏死性细胞死亡途径中的作用。当细胞因子反应调节因子A(CrmA),一种病毒来源的丝氨酸蛋白酶抑制剂样半胱天冬酶抑制剂,在L929细胞中稳定过表达时,后者对TNF介导的细胞死亡的敏感性提高了1000倍。此外,当细胞分别用Ac-YVAD-cmk或zDEVD-fmk预处理时,也观察到了TNF敏感性增加,这两种试剂分别抑制半胱天冬酶-1样和半胱天冬酶-3样蛋白酶。两种半胱天冬酶的广谱抑制剂zVAD-fmk和zD-fmk也使细胞更敏感,因为TNF介导的坏死的半数最大剂量降低了1000倍。zVAD-fmk的存在还导致TNF介导的氧自由基产生更快增加。氧自由基清除剂丁基羟基茴香醚可以完全抑制zVAD-fmk依赖性的TNF细胞毒性致敏作用。这些结果表明半胱天冬酶参与了对TNF诱导的氧自由基形成和坏死的保护作用。